IFNG and myopathy: While CXCL10 is predominantly associated with a Th1 response, it has been recently identified in inflammatory myopathies [45, 46], and secretion of CXCL10 from human fetal skeletal muscle cells is induced by treatment with either interferon (IFN)-γ or TNFα [45].